acut
rhinosinus
ar
common
infecti
diseas
apart
person
discomfort
reduc
qualiti
life
vast
social
econom
impact
concept
rhinosinus
introduc
recent
year
inflamm
prove
occur
simultan
nose
paranas
sinus
case
common
cold
rhiniti
symptom
consid
ar
accord
european
posit
paper
rhinosinus
nasal
polyp
epo
ar
characteris
apart
inflamm
nasal
passag
paranas
sinus
two
specif
symptom
nasal
congest
nasal
discharg
besid
facial
painpressur
anosmiahyposmia
may
occur
addit
symptom
fever
asthenia
headach
may
observ
rule
ar
selflimit
diseas
last
day
ar
includ
viral
phase
acut
viral
rhinosinus
postvir
phase
epo
term
viral
ar
chosen
indic
ar
case
bacteri
ar
may
diagnos
acut
bacteri
rhinosinus
abr
typic
abr
symptom
includ
nasal
discharg
unilater
facial
pain
tender
palpat
area
sinu
project
children
older
year
toothach
subsequ
exacerb
primari
amelior
hyperthermia
neutrocytosi
acut
rhinosinus
fifth
frequent
diagnosi
antibiot
prescript
although
evid
antibacteri
therapi
reduc
durat
diseas
frequent
groundless
use
antibiot
caus
increas
resist
result
need
altern
therapeut
strategi
base
scientif
data
main
caus
ar
first
day
diseas
basic
number
virus
rhinoviru
parainfluenza
viru
type
type
coronaviru
influenza
viru
increas
concentr
proinflammatori
cytokin
neutrophil
addit
activ
lead
disord
mucociliari
clearanc
due
damag
ciliat
cell
well
increas
thick
secret
chang
lead
gradual
deterior
qualiti
ostiomeat
complex
disord
ventil
drainag
paranas
sinus
similar
type
reaction
also
observ
context
bacteri
infect
thu
ar
may
easili
misdiagnos
bacteri
infect
therefor
groundlessli
treat
antibiot
contribut
recoveri
stage
diseas
common
strategi
treatment
acut
viral
rhinosinus
reduc
symptom
sever
minimis
diseas
durat
prevent
transform
postvir
bacteri
rhinosinus
well
prevent
progress
chronic
diseas
use
antibiot
nasal
decongest
antihistamin
homeopath
medicin
mucolyt
agent
acut
viral
rhinosinus
groundless
benefit
yet
prove
accord
epo
pharmaceut
symptomat
treatment
acut
viral
rhinosinus
includ
therapeut
irrig
isoton
sea
salt
solut
nonsteroid
antiinflammatori
drug
antipyret
nsaid
aspirin
paracetamol
altern
strategi
use
herbal
medicin
abl
suppress
number
patholog
process
one
exampl
complex
herbal
medicin
includ
gentian
primula
elder
verbena
sorrel
proven
herbal
medicin
intensifi
ciliari
activ
vitro
show
antiinflammatori
activ
experi
anim
wide
rang
pharmacolog
properti
includ
mucolyt
secretomotor
antivir
antiinflammatori
immunomodulatori
action
jund
et
al
conduct
randomis
doubleblind
placebocontrol
studi
adult
patient
acut
viral
rhinosinus
activ
treatment
group
receiv
daili
dose
mg
phytoprepar
within
day
activ
treatment
group
show
signific
improv
compar
placebo
group
base
result
sinonas
test
includ
total
index
nasal
symptom
rhinogen
symptom
overal
qualiti
life
studi
efficaci
syrup
treatment
viral
ar
schoolag
children
year
old
conduct
previous
report
result
randomis
control
studi
children
age
year
appli
syrup
studi
similar
trial
conduct
adult
jund
et
al
studi
prospect
multicentr
intervent
randomis
studi
viral
ar
treatment
children
age
year
studi
compar
complex
phytotherapeut
treatment
syrup
combin
therapeut
irrig
standard
therapeut
irrig
tabl
herbal
medicin
wide
use
treatment
differ
respiratori
tract
diseas
includ
rhinosinus
composit
mixtur
deriv
part
four
plant
gentian
root
radix
gentiana
primros
flower
calyx
flore
primula
cum
calibu
flower
elderberri
flore
sambuci
european
vervain
herb
herba
verbena
sorrel
grass
herba
group
receiv
symptomat
medic
paracetamol
nasal
decongest
necessari
group
appli
therapeut
irrig
isoton
sea
salt
solut
four
time
daili
group
addit
receiv
herbal
medicin
syrup
three
time
daili
agespecif
dosag
ml
studi
popul
consist
children
boy
girl
use
method
opaqu
seal
sequenti
number
envelop
children
distribut
group
children
control
group
main
inclus
criteria
acut
viral
rhinosinus
acut
symptom
h
total
score
sinus
sever
point
accord
major
sinus
sever
score
mss
score
assess
mss
score
five
key
symptom
rate
physician
point
per
symptom
sum
maximum
mss
score
point
nasal
discharg
nasal
congest
postnas
drip
headach
facial
pain
slight
sever
administr
herbal
medicin
within
day
prior
first
manifest
rhinosinus
diagnosi
allerg
rhinosinus
known
intoler
primros
drug
sever
acut
diseas
requir
hospitalis
treatment
antibiot
administr
topic
corticosteroid
immun
defici
chronic
patholog
anatom
anomali
ostiomeat
complex
may
influenc
outcom
diseas
studi
period
four
visit
conduct
visit
day
visit
day
visit
day
visit
day
symptom
assess
physician
patient
five
key
symptom
nasal
discharg
nasal
congest
postnas
drip
headach
facial
pain
assess
physician
point
per
symptom
visit
addit
key
complaint
rhinorrhoea
headach
facial
pain
assess
daili
patient
parent
use
visual
analogu
scale
primari
criteria
improv
symptom
secondari
criteria
frequenc
transit
antibiot
prescript
exacerb
day
persist
symptom
day
durat
diseas
data
analys
descript
differ
two
group
analys
use
pair
ttest
use
twosid
confid
interv
ci
p
indic
statist
signific
trial
regist
german
clinic
trial
regist
retrospect
march
trial
acronym
arsich
drksid
one
hundr
sixtynin
patient
complet
studi
period
day
total
patient
group
patient
control
group
exclud
studi
due
protocol
violat
data
patient
exclud
analysi
thu
data
patient
group
patient
control
group
use
analysi
visit
day
patient
group
patient
control
group
show
continu
exacerb
symptom
day
sign
bacteri
inflamm
postvir
rhinosinus
diagnos
patient
howev
differ
statist
signific
similar
trend
without
statist
signific
also
observ
regard
term
recoveri
group
durat
diseas
day
vs
day
control
group
total
patient
group
take
antibiot
compar
patient
control
group
differ
statist
signific
p
case
patient
antibiot
administr
initi
time
visit
due
rise
bodi
temperatur
higher
sinus
symptom
exacerb
symptom
assess
physician
figur
show
physician
assess
rhinoscopi
dynam
nasal
congest
symptom
visit
group
show
compar
symptom
visit
visit
visit
nasal
congest
significantli
lower
group
control
group
p
p
respect
visit
visit
nasal
congest
group
show
symptom
reduct
patient
symptomfre
visit
figur
show
physician
assess
nasal
discharg
symptom
visit
differ
index
visit
statist
signific
p
visit
visit
decreas
symptom
intens
howev
betweengroup
differ
reach
statist
signific
anymor
figur
show
physician
assess
postnas
drip
symptom
pharyngoscopi
less
sever
group
control
group
visit
vs
point
p
visit
visit
group
show
symptom
reduct
without
statist
signific
physician
assess
headach
also
show
symptom
slightli
less
sever
group
compar
control
group
visit
vs
differ
signific
statist
signific
differ
observ
regard
facial
pain
group
figur
show
physician
assess
consolid
figur
point
sinus
sever
five
symptom
visit
day
signific
differ
group
p
favour
treatment
group
observ
symptom
reduct
persist
time
howev
betweengroup
comparison
becom
statist
insignific
visit
visit
figur
show
patient
selfassess
parent
help
condit
averag
score
first
day
treatment
three
symptom
rhinorrhoea
facial
pain
headach
score
per
symptom
begin
studi
day
patient
assess
group
similar
significantli
lower
level
main
complaint
found
group
day
p
gener
patient
selfassess
symptom
dynam
consist
assess
provid
physician
visit
statist
signific
differ
group
acut
viral
rhinosinus
preval
econom
import
diseas
involv
inflamm
nasal
mucosa
paranas
sinus
convent
fig
physician
assess
dynam
nasal
congest
symptom
visit
averag
score
mss
scale
point
p
signific
differ
group
fig
physician
assess
nasal
discharg
symptom
visit
averag
score
mss
scale
point
p
signific
differ
group
gold
standard
ar
treatment
antibiot
indic
treatment
uncompl
ar
salin
irrig
prove
effici
improv
symptom
randomis
placebocontrol
studi
sinc
complex
herbal
prepar
includ
nation
clinic
guidelin
treatment
acut
rhinosinus
ukrain
extens
evid
vitro
vivo
studi
complex
herbal
medicin
possess
varieti
relev
activ
antiinflammatori
action
stimul
transepitheli
chlorid
transport
enhanc
ciliari
beat
frequenc
antivir
activ
limit
knowledg
benefici
effect
herbal
medicin
treatment
ar
children
previou
studi
investig
effect
children
acut
postvir
rs
posit
effect
current
studi
result
show
administr
herbal
drug
syrup
ml
time
daili
effect
treatment
acut
viral
rhinosinus
children
age
applic
herbal
prepar
togeth
salin
irrig
symptomat
treatment
give
faster
recoveri
symptom
give
higher
rate
complet
recoveri
without
use
antibiot
studi
use
irrig
therapi
group
compon
basic
therapi
local
activ
impact
irrig
therapi
assum
similar
group
sinc
group
paramet
compar
evalu
differ
sever
symptom
dynam
group
therefor
assum
herbal
medicin
action
addit
herbal
medicin
multipl
systemat
activ
could
use
allevi
symptom
acut
viral
rhinosinus
might
inhibit
transit
bacteri
infect
postvir
rhinosinus
compar
standard
treatment
sinupret
group
signific
improv
observ
three
five
key
symptom
assess
physician
nasal
congest
assess
patient
gener
assess
symptom
dynam
physician
patient
consist
reduct
number
patient
take
antibiot
trend
toward
reduct
diseas
durat
transit
diseas
postvir
rhinosinus
also
observ
howev
differ
two
paramet
consid
statist
signific
studi
patient
postvir
rhinosinus
similar
result
observ
present
studi
none
patient
show
advers
reaction
syrup
fact
may
due
rel
small
number
particip
howev
confirm
good
toler
medicin
form
syrup
use
children
openlabel
randomis
intervent
studi
limit
includ
absenc
virolog
inform
radiolog
data
small
sampl
size
limit
accuraci
result
diseas
durat
frequenc
antibiot
prescript
group
effect
treatment
acut
viral
rhinosinus
children
acceler
relief
main
symptom
also
help
reduc
extens
antibiot
prescript
condit
reduc
possibl
diseas
progress
phase
postvir
rhinosinus
seem
import
view
necess
reduc
undu
prescript
antibiot
develop
bacteri
resist
abbrevi
abr
acut
bacteri
rhinosinus
ar
acut
rhinosinus
cftr
cystic
fibrosi
transmembran
conduct
regul
epo
european
posit
paper
rhinosinus
nasal
polyp
mss
score
major
sinus
sever
score
visit
bionorica
se
support
present
result
studi
cover
cost
medic
writer
statist
data
process
translat
articl
english
avail
data
materi
relev
data
present
manuscript
patient
selfassess
condit
first
day
treatment
three
symptom
rhinorrhea
facial
pain
headach
p
signific
differ
group
